Home LiteratureArticle Details
PMID: 2878129 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs.

Lancet (London, England) ·Vol. 2 ·No. 8518 ·1986-11-29 ·Pages 1233-6

Allain JP, Laurian Y, Paul DA, Senn D

Abstract

Immunoassays for human immunodeficiency virus antigen (HIV Ag) and for antibody to HIV core and envelope (CIA-RA) were done on serial specimens from 40 haemophiliacs who had become seropositive on screening by enzyme-linked immunosorbent assay (ELISA). HIV Ag was detectable in 9 subjects and antibodies to envelope in 11 subjects before ELISA seroconversion. The apparent sequence of markers is HIV Ag, antibody to envelope, then antibody to core. Antigenaemia could be detected as soon as 2 weeks after infection and lasted 3-5 months. 82% agreement was seen between CIA-RA and western blot; CIA was more sensitive to envelope antibody and western blot was more sensitive to core antibody.

MeSH Terms
Acquired Immunodeficiency Syndrome/diagnosis Adolescent Adult Antibodies, Viral/analysis Antigens, Viral/analysis Child Enzyme-Linked Immunosorbent Assay HIV/immunology Hemophilia A/complications Humans Immunoenzyme Techniques Time Factors Viral Core Proteins/immunology Viral Envelope Proteins/immunology
Chemicals
Antibodies, Viral Antigens, Viral Viral Core Proteins Viral Envelope Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Allain J P
Laurian Y
Paul D A
Senn D
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1986-11-29
Pages
1233-6
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]